semaglutide deaths uk NICE recommends injections to prevent heart attack and stroke Canada approves Ozempic to cut
Description
The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits
HbA1c 2.0% 2 , , ,
Neither tirzepatide nor semaglutide has demonstrated liver fat reductions approaching the 80%+ figures seen with retatrutide
two leads to a discount of 50 per cent off the brand
